A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation.
A new interesting article has been published in J Exp Clin Cancer Res. 2019 May 22;38(1):211. doi: 10.1186/s13046-019-1207-y. and titled: A low-molecular-weight compound exerts anticancer activity against breast and lung…
